September 19, 2008
Interleukin and Geisinger Collaborate in Obesity Research
Interleukin Genetics, which develops preventive consumer products and genetic tests, and Geisinger Health System, an integrated health services organization, have announced a research collaboration to explore the role of genetics in obesity.
The goal of the collaboration is to develop a series of genetic tests that will help physicians better understand an individual's inherited resistance to weight loss and, more specifically, gauge a patient's likelihood of success with diet and other weight loss techniques.
Geisinger and Interleukin Genetics will engage in a case-control retrospective study involving the analysis of DNA to better understand genetic links to obesity. The study will focus exclusively on variations of perilipin, interleukin 1 and a select number of other genes.
Lewis Bender, CEO of Interleukin Genetics, said: "We are pleased to be working with Geisinger to develop an accurate and affordable genetic test as a predictor of weight loss success. This relationship allows our scientists to build on Geisinger's extensive clinical expertise and biobank."